STIM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Neuronetics Inc

Watchlist Manager

Watchlist

Price: 2.91 USD Market Closed

Market Cap: $202.5m

	Neuronetics Inc NASDAQ:STIM	US
	4D Molecular Therapeutics Inc NASDAQ:FDMT	US
S	SoftBank Group Corp OTC:SFTBY	JP

Profitability Summary

Neuronetics Inc's profitability score is 19/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

64%

Declining Gross Margin

75% > 49%

Negative Operating Margin

-15%

Negative 3Y Average Operating Margin

-35%

Operating Margin is Increasing

-48% > -15%

Negative Net Margin

-20%

Negative 3Y Average Net Margin

-40%

Net Margin is Increasing

-46% > -20%

Negative Free Cash Flow Margin

-7%

Negative 3Y Average Free Cash Flow Margin

-32%

Free Cash Flow Margin is Increasing

-53% > -7%

Negative ROE

-135%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-47%

ROIC is Increasing

-65% > -21%

View All

Hide

Collapse

19 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.